Theater review PURPOSE .review-block-star --review-block-star--empty-color: #585858; --review-block-star--fill-color: #000; ...

Zevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party.

(Alliance News) - Stock prices in London closed higher on Monday, as investors appear to remain unphased by US President Donald Trump's earlier threats of 25% tariffs on steel and aluminium imports.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The US-based company received the PRV when its Niemann-Pick disease type C drug Miplyffa (arimoclomol) won FDA approval in September 2024. Zevra plans to use the funds from the voucher sale to ...

Emerson recently launched the Anderson Greenwood Type 84 Pressure Relief Valve (PRV), which is specially designed to protect tanks and vessels used in hydrogen and other high-pressure gas applications ...

The Arizona Wildcats men’s basketball team found themselves back in The Associated Press’ Top 25 released Monday.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Pharming has agreed a deal to sell a recently awarded priority review voucher (PRV) to Novartis for around $21 million - well below the market rate. The price of PRVs, which can be used to shorten ...